Lipocine Inc. (LPCN) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY, 84108 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 21,633 | 22,036 | 32,530 | 44,618 | 19,667 | 14,069 | |||
| Cash and cash equivalent | 6,206 | 4,772 | 3,148 | 2,951 | 19,217 | 9,729 | |||
| Short-term investments | 15,427 | 17,264 | 29,381 | 41,667 | 450 | 4,340 | |||
| Receivables | 120 | 52 | 80 | 247 | 0 | 17 | |||
| Contract with customer, asset, after allowance for credit loss | 579 | ||||||||
| Other undisclosed current assets | 568 | 773 | 945 | 1,514 | 5,661 | 5,546 | |||
| Total current assets: | 22,322 | 22,861 | 34,135 | 46,380 | 25,329 | 19,631 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 165 | 116 | 132 | 7 | 4 | ||||
| Long-term investments and receivables | 2,022 | ||||||||
| Long-term investments | 2,022 | ||||||||
| Contract with customer, asset, after allowance for credit loss | 3,253 | 4,050 | |||||||
| Other noncurrent assets | 24 | 24 | 24 | 24 | 24 | 24 | |||
| Total noncurrent assets: | 189 | 140 | 3,408 | 6,103 | 24 | 27 | |||
| TOTAL ASSETS: | 22,511 | 23,001 | 37,543 | 52,482 | 25,353 | 19,658 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 1,193 | 2,614 | 1,678 | 2,306 | 3,250 | 1,632 | |||
| Accounts payable | 272 | 1,396 | 600 | 1,289 | 1,597 | 1,182 | |||
| Accrued liabilities | 921 | 1,218 | 1,078 | 1,016 | 1,653 | 449 | |||
| Debt | 2,311 | 3,333 | 3,333 | ||||||
| Estimated litigation liability | 1,000 | ||||||||
| Other undisclosed current liabilities | 320 | 17 | |||||||
| Total current liabilities: | 1,513 | 2,632 | 1,678 | 5,617 | 6,584 | 4,965 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 2,257 | 3,814 | |||||||
| Long-term debt, excluding current maturities | 2,257 | 3,814 | |||||||
| Liabilities, other than long-term debt | 500 | ||||||||
| Estimated litigation liability | 500 | ||||||||
| Other undisclosed noncurrent liabilities | 230 | 796 | 1,170 | 4,591 | |||||
| Total noncurrent liabilities: | 230 | 1,296 | 3,427 | 8,406 | |||||
| Total liabilities: | 1,513 | 2,632 | 1,908 | 6,912 | 10,011 | 13,370 | |||
| Equity | |||||||||
| Equity, attributable to parent | 20,998 | 20,369 | 35,635 | 45,570 | 15,342 | 6,288 | |||
| Common stock | 9 | 9 | 9 | 9 | 7 | 4 | |||
| Treasury stock, value | (41) | (41) | (41) | (41) | (41) | (41) | |||
| Additional paid in capital | 220,789 | 220,171 | 219,112 | 218,286 | 187,408 | 157,392 | |||
| Accumulated other comprehensive income (loss) | 9 | 7 | (20) | (18) | (0) | ||||
| Accumulated deficit | (199,769) | (199,777) | (183,425) | (172,666) | (172,032) | (151,067) | |||
| Total equity: | 20,998 | 20,369 | 35,635 | 45,570 | 15,342 | 6,288 | |||
| TOTAL LIABILITIES AND EQUITY: | 22,511 | 23,001 | 37,543 | 52,482 | 25,353 | 19,658 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 11,198 | (2,851) | 500 | 16,141 | 165 | |||
| Gross profit: | 11,198 | (2,851) | 500 | 16,141 | 165 | |||
| Operating expenses | (12,353) | (15,080) | (12,619) | (12,995) | (17,996) | (13,065) | ||
| Operating income (loss): | (1,155) | (17,931) | (12,119) | 3,146 | (17,996) | (12,900) | ||
| Nonoperating income (expense) | 1,164 | 1,580 | 1,361 | (3,780) | (2,968) | (343) | ||
| Investment income, nonoperating | 1,147 | 1,367 | ||||||
| Other nonoperating income (expense) | 1,361 | (3,780) | (2,968) | (343) | ||||
| Interest and debt expense | (27) | (203) | 235 | |||||
| Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | (235) | 236 | ||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | 9 | (16,351) | (10,785) | (837) | (20,965) | (13,007) | ||
| Other undisclosed income from continuing operations before income taxes | 27 | 203 | ||||||
| Income (loss) from continuing operations before income taxes: | 9 | (16,351) | (10,758) | (634) | (20,965) | (13,007) | ||
| Income tax expense | (1) | (1) | (1) | (0) | (0) | (0) | ||
| Income (loss) from continuing operations: | 8 | (16,352) | (10,759) | (634) | (20,965) | (13,007) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (634) | (20,965) | (13,007) | |
| Net income (loss) attributable to parent: | 8 | (16,352) | (10,759) | (634) | (20,965) | (13,007) | ||
| Preferred stock dividends and other adjustments | (0) | |||||||
| Net income (loss) available to common stockholders, basic: | 8 | (16,352) | (10,759) | (634) | (20,965) | (13,007) | ||
| Other undisclosed net loss available to common stockholders, diluted | (17) | (213) | (566) | |||||
| Net loss available to common stockholders, diluted: | (9) | (16,565) | (11,325) | (634) | (20,965) | (13,007) | ||
Comprehensive Income ($ in thousands)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 8 | (16,352) | (10,759) | (634) | (20,965) | (13,007) | ||
| Comprehensive income (loss): | 8 | (16,352) | (10,759) | (634) | (20,965) | (13,007) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 2 | 28 | (2) | (18) | 0 | 1 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 10 | (16,325) | (10,761) | (652) | (20,965) | (13,006) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.